Creative Biolabs Introduced One-stop ADC Development Service

November 2719:482017

As a professional biology company focused on antibody-drug conjugate (ADC) development, Creative Biolabs introduced elaborately a comprehensive one-stop ADCdevelopment service to help create highly customized ADCs, covering every step from the starting point—antibody identification, to the final destination—creation and evaluation of the ADC.

What is ADC? Consisting of three main components including the monoclonal antibody, a cytotoxic payload, and a molecular linker, ADC meaning in antibody engineering generally refers to antibody-drug conjugate. A successful ADC should be chemically and physiologically stable in the blood stream, which exerts similar antigen binding pattern compared with the unconjugated antibody, and exhibits ideal payload toxicological effects once internalized.

“The ADC designing process is a challenging task in a sense. We all know that ADC development not only involves careful planning, meticulous execution, but also intensive trouble-shooting. And each part of this process is never tolerant of any mistake.” introduced Dr. Monika Müller, scientific officer of Creative Biolabs.

“With this concept in mind, our team has perfected our ADC development services, which are divided into six independent yet interconnected modules, just like the relationship between each component in an ADC. To be honest, I am so proud of what they have done and I firmly believe that our team will create more and more advanced technologies and services.”

Monoclonal antibody-based immunotherapies against cancer and other infectious diseases are highly advantageous comparing to conventional therapeutic approaches due to their high specificity and affinity towards well-defined targets. With Ph.D. level scientists and over a decade of experience in recombinant antibody production, antibody engineering, synthetic chemistry, and bio-conjugation, Creative Biolabs is dedicated to serving the unique needs of clients in ADC development projects by providing customized services that are tailored to meet R&D timeline and budget.

About Creative Biolabs

Established in 2004, Creative Biolabs is highly specialized in advanced antibody biochemistry and engineering. With more than a decade of exploration and expansion, our current research and service capacity covers the entire new drug discovery and development pipeline, ranging from early discovery, preclinical evaluations, cGMP manufacturing, to clinical trails. As an international cooperation, we have established offices all around the globe with more than 200 well-trained full-time scientists and technicians, who work closely with our customers and research partners to develop new medicines for a better, healthier world.